RAFFERTY ASSET MANAGEMENT, LLC – Global Blood Therapeutics, Inc. Transaction History
RAFFERTY ASSET MANAGEMENT, LLC portfolio value:
$6.97M
portfolio value
RAFFERTY ASSET MANAGEMENT, LLC quarter portfolio value change:
+113.15%
quarter
Global Blood Therapeutics, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -40.36% | -69.29K shares | 1.48M | $68.1 | 102.39K |
Q2 2022 | share | Decrease | -12.09% | -23.60K shares | -1.28M | $31.95 | 171.68K |
Q1 2022 | share | Increase | +0.74% | 1.42K shares | 1.09M | $34.64 | 195.29K |
Q4 2021 | share | Increase | +68.02% | 78.48K shares | 2.73M | $29.86 | 193.86K |
Q3 2021 | share | Increase | +79.77% | 51.2K shares | 692K | $25.48 | 115.38K |
Q2 2021 | share | Decrease | -15.19% | -11.49K shares | -836K | $35.02 | 64.18K |
Q1 2021 | share | Increase | +229.34% | 52.69K shares | 2.08M | $40.75 | 75.67K |
Q4 2020 | share | Decrease | -38.90% | -14.62K shares | -1.07M | $43.31 | 22.97K |
Q3 2020 | share | Increase | +146.64% | 22.35K shares | 1.11M | $55.14 | 37.60K |
Q2 2020 | share | Increase | +153.75% | 9.23K shares | 656K | $63.13 | 15.24K |
Q1 2020 | share | Decrease | -88.22% | -45.02K shares | -3.74M | $51.09 | 6.00K |
Q4 2019 | share | Decrease | -57.47% | -68.94K shares | -1.76M | $79.49 | 51.02K |
Q3 2019 | share | Increase | +30.99% | 28.38K shares | 1.00M | $48.52 | 119.97K |
Q2 2019 | share | Decrease | -7.63% | -7.56K shares | -430K | $52.6 | 91.58K |
Q1 2019 | share | Increase | 0.00% | 99.14K shares | 5.24M | $52.93 | 99.14K |